FDA Concludes That A New Regulatory Pathway For CBD Is Neede

On January 26, the U.S. Food and Drug Administration (FDA or the Agency) announced that it is prepared to work with Congress to develop a new regulatory pathway for cannabidiol (CBD).

Related Keywords

Buchanan Ingersoll , Flurry Of Warning Letters To Companies Making , Warns Four Companies For Illegally Selling , Drug Administration , Companies Jan , Warns Companies Illegally Selling , Warns Companies For Illegally Selling Food , Warning Letters , Cosmetic Act , Existing Regulatory Frameworks , Not Appropriate , New Way Forward , Three Citizen Petitions , Dietary Supplements , Companies Making Unapproved , Illegally Selling Food , Beverage Products , Four Companies , Illegally Selling , Products Intended , Food Producing Animals , Companies Illegally Selling , Mondaq , Fda Concludes Thata New Regulatory Pathway For Cbd Is Needed , Cannabis Amp Hemp , Corporate Commercial Law , Corporate And Company Law , Food , Drugs , Healthcare , Life Sciences , Food And Drugs Law , ,